Letrozole

A to Z Drug Facts

Letrozole

  Action
  Indications
  Contraindications
  Route/Dosage
  Interactions
  Lab Test Interferences
  Adverse Reactions
  Precautions
Patient Care Considerations
  Administration/Storage
  Assessment/Interventions
  Patient/Family Education


(let-ROW-zahl)
Femara
Tablets
2.5 mg.
Class: Nonsteroidal aromatase inhibitor

 Action A nonsteroidal competitive inhibitor of the aromatase enzyme system; it inhibits the conversion of androgens to estrogens. Elimination half-life is approximately 2 days. It is weakly protein bound. Renal excretion is the major pathway of letrozole clearance.

 Indications Advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy; first-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic cancer.

 Contraindications Standard considerations.

 Route/Dosage

Breast Cancer Adults: PO 2.5 mg once daily (tablets).

 Interactions

Contraceptives, oral May alter the efficacy of oral contraceptives.

Tamoxifen Plasma concentrations of letrozole may be decreased.

 Lab Test Interferences None well documented.

 Adverse Reactions

CARDIOVASCULAR: Chest pain; hypertension; peripheral edema. CNS: Decreased appetite; fatigue; headache; insomnia; somnolence; dizziness; asthenia; weakness. DERMATOLOGIC: Rash; pruritis; alopecia. GI: Nausea and vomiting; constipation; diarrhea; abdominal pain; anorexia; dyspepsia. GU: Sexual inactivity; atrophy of the female reproductive organs; breast pain. METABOLIC: Hot flashes; weight gain; hypercholesterolemia; weight loss. RESPIRATORY: Dyspnea; coughing. OTHER: Viral infections; musculoskeletal pain; arthralgia; flu-like symptoms.

 Precautions

Pregnancy: Category D. Lactation: Undetermined. Children: Safety and efficacy not established. Hepatic function impairment: Use caution in patients with severe hepatic dysfunction.


PATIENT CARE CONSIDERATIONS


 Administration/Storage

 Assessment/Interventions

 Patient/Family Education

Books@Ovid
Copyright
© 2003 Facts and Comparisons
David S. Tatro
A to Z Drug Facts